Sight Sciences (SGHT) Capital Expenditures Growth (3y) (2023 - 2026)
Sight Sciences (SGHT) Capital Expenditures Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.83 Bn | 176.54 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.62 Bn | 99.40 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 28.18 Bn | 25.90 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.68 Bn | 21.55 Bn | 2.07 Bn | 2.15% |
| 10 | Sight Sciences | 273.49 Mn | 188.53 Mn | 16.98 Mn | 66.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.50% |
| Dec 31, 2025 | 34.83% |
| Sep 30, 2025 | -40.50% |
| Jun 30, 2025 | 68.37% |
| Dec 31, 2024 | -48.20% |
| Sep 30, 2024 | -43.78% |
| Jun 30, 2024 | 32.36% |
| Mar 31, 2024 | -26.24% |
| Dec 31, 2023 | 27.30% |
| Sep 30, 2023 | 22.92% |